#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Richter's syndrome Orthostatic hypotension Small cell lung cancer recurrent Univentricular heart Angiosarcoma recurrent Bronchiectasis Hepatitis D Neuropathic arthropathy Ataxia telangiectasia Short-bowel syndrome Inclusion body myositis Phaeochromocytoma Pseudomyxoma peritonei Cervix carcinoma recurrent Autoimmune demyelinating disease More trials…

    Learn about Rare Diseases

    Angiosarcoma – Trials in Disease Gaucher’s disease type I – Basic Information Synovial sarcoma – Treatment Cystic fibrosis lung – Life with Disease Richter’s syndrome – Basic Information Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Alexander disease – Trials in Disease Osteosarcoma metastatic – Treatment Leukoencephalopathy – Life with Disease Carcinoid syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ubamatamab Ambrisentan Sulfamethoxazole Obeticholic Acid Dried Ferrous Sulfate Camizestrant Metyrapone Bp Iron Cefotaxime Ponsegromab Gilteritinib Glimepiride VISUGROMAB Heparin Sodium Diclofenac Epolamine Minocycline ZOREVUNERSEN SODIUM Valaciclovir Feladilimab Human Immunoglobulin G More therapies…

    Learn about Your Condition

    Thromboembolectomy Myocardial ischaemia Tendon disorder Skin angiosarcoma Cluster headache Transplantation complication Multiple sclerosis relapse Von Hippel-Lindau disease Tricuspid valve disease Infertility female Escherichia infection Myeloid leukaemia Cardiac disorder Venous thrombosis EGFR gene mutation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Lisdexamfetamine and Methylphenidate for Children with ADHD and Type 1 Diabetes

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Attention deficit hyperactivity disorder
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Lisdexamfetamine Dimesylate
    • Methylphenidate Hydrochloride
    Poland

  • Study on the Effects of Rivaroxaban in Patients with Short Bowel Syndrome on Long-Term Parenteral Nutrition

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Short-bowel syndrome
    Investigated Drugs:
    • Rivaroxaban
    The Netherlands

  • Study on the Physical Impact of Multiple Sclerosis and Continued Access to Ocrelizumab for Patients Previously in a Related Study

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ocrelizumab
    Bulgaria France Germany

  • Study on the Effect of Lutropin Alfa to Improve Ovarian Reserve in Patients Undergoing IVF/ICSI Due to Tubal, Male Factor, or Unexplained Infertility

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Lutropin Alfa
    Italy

  • Study on Cemiplimab for Patients with High-Risk Stage III/IV Cutaneous Squamous Cell Carcinoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of skin
    Investigated Drugs:
    • Cemiplimab
    Italy

  • Study on the Safety of Faster Infusions for Cancer Patients Using Trastuzumab, Bevacizumab, and Atezolizumab

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Inflammatory bowel disease
    • Rheumatic disorder
    Investigated Drugs:
    • Vedolizumab
    • Ipilimumab
    • Atezolizumab
    The Netherlands
Previous Page
1 … 309 310 311 312 313 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!